Stock·NASDAQ·Communication Services
Comcast Corp. (CMCSA)
- Market cap
- $77.25B
- P/E
- 6.74
- Dividend yield
- 6.06%
- Street target
- $28.00median of 28 analysts
- 52-week range
- $20.48 $32.86
The short version
Where CMCSA stands today, in four lines, and what CleaRank Financial AI makes of it.
CMCSA at a glance
Comcast Corp. (CMCSA): Hold, 54/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($24.19 and $26.40).
- Earnings CMCSA beat estimates in 5 of its last 5 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $2.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 6.7 against 23.3 for the Communication Services sector: a discount to peers (-71%).
Figures as of October 16, 2026.
CleaRank Financial AI
Comcast Corp. (CMCSA) is trading at $21.77, below its 50-day and 200-day moving averages ($24.19 and $26.40), indicating a bearish technical trend.
The company's valuation appears attractive with a P/E ratio of 6.74, significantly lower than the sector median of 23.3, and a price-to-sales ratio of 0.59 compared to the sector average of 2.5. However, revenue growth has been negative at -1.2%, and forward estimates suggest continued contraction. Despite these challenges, Comcast maintains a substantial dividend yield of 6.06%. Recent earnings have shown consistent EPS beats, with the latest quarter exceeding estimates by 7.22%. The company's profit margin stands at 8.97% and operating margin at 17.23%, with a return on equity of 11.49%, which is below the sector average of 15.8%. The debt-to-equity ratio is 1.00, in line with the sector average.
Only on CleaRank
Figures we compute ourselves from CMCSA's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $21.77 is 10.0% below the 50-day simple moving average of $24.19.Price above its 200-day average ›
The price is 17.6% below the 200-day simple moving average of $26.40.50-day average above the 200-day ›
The 50-day average ($24.19) is 8.4% below the 200-day average ($26.40), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 10% of its 52-week range, between $20.48 and $32.86.
CMCSA share price
Pick a period: each tab shows how far CMCSA has moved over it, to the last close.
Today's trading
Where CMCSA sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 6.74 is 71.1% below the Communication Services median of 23.3.P/S below the sector median ›
The price-to-sales ratio of 0.59 is 76.3% below the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $11.2B on revenue of $124.9B, a net margin of 9.0%.Beat estimates in most recent reports ›
CMCSA beat the EPS estimate in 5 of its last 5 reports.Pays a dividend ›
The trailing dividend yield is 6.06%, or $1.32 a share a year.
Key statistics
The headline figures for CMCSA.
As of October 16, 2026, CMCSA trades at $21.77, with a market value of $77.25B, a P/E ratio of 6.74 and a dividend yield of 6.06%.
What the numbers say
CleaRank Financial AI's reading of CMCSA's valuation, growth and risks.
Comcast Corp. (CMCSA) presents a mixed fundamental picture, trading at a P/E ratio of 6.74, which is substantially lower than the Communication Services sector median of 23.3, suggesting a potential value opportunity.
Its price-to-sales ratio of 0.59 is also well below the sector average of 2.5. However, the company is experiencing negative revenue growth at -1.2%, with forward estimates projecting further declines. The company's profitability metrics show a net profit margin of 8.97% and an operating margin of 17.23%, with a return on equity of 11.49%, which lags the sector median of 15.8%. The debt-to-equity ratio stands at 1.00, aligning with the sector average. While valuation multiples are attractive, the declining revenue and below-average ROE warrant caution.
CMCSA against the Communication Services sector
How CMCSA compares with the median Communication Services stock CleaRank tracks.
Price to earnings vs sector: CMCSA trades at a notable discount to sector peers (-71%), which may indicate undervaluation or specific company headwinds.
Return vs VOX: Since May 5, 2025, CMCSA has lost 31.9% against a gain of 27.5% for VOX.
Performance against VOX
CMCSA and the Communication Services sector fund over the same days.
Revenue and earnings
How much CMCSA sells, and how much of it becomes profit.
Revenue growth: Revenue fell 0.0% in FY2025 to $124B, from $124B a year earlier.
Profit margin: The net margin was 15.9% in FY2025, up from 12.8% the year before.
Profitable: CMCSA earned $19.7B in FY2025.
Earnings reality check
Did CMCSA beat what analysts expected, and how did the stock react?
Earnings record: CMCSA beat the analyst estimate in 5 of the last 5 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.97 | $1.04 | +7.22% | +1.73% | +7.98% |
| Jan 29, 2026after close | $0.76 | $0.84 | +10.53% | +1.74% | +5.51% |
| Oct 30, 2025after close | $1.10 | $1.12 | +1.82% | +1.90% | -0.04% |
| Jul 31, 2025after close | $1.18 | $1.25 | +5.93% | -2.14% | -4.69% |
| Apr 24, 2025after close | $0.99 | $1.09 | +10.10% | +2.14% | +1.90% |
As of October 16, 2026, CMCSA has beaten the analyst EPS estimate in 5 of its last 5 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 23, 2026, came in 7.22% above the estimate and the stock moved +1.73% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 45.8, in neutral territory.RSI above 50 ›
An RSI of 45.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CMCSA
The score, the reasoning behind it, and what could move the price next.
Comcast Corp. (CMCSA) is currently trading below its 50-day SMA of $24.19 and its 200-day SMA of $26.40, signaling a bearish trend.
The 14-day RSI is at 45.8, indicating neutral momentum, while the MACD is negative at -0.84, suggesting downward pressure. Volume has been 11.8% above its average, indicating increased trading activity as the stock moves lower. The current price of $21.77 is below the 20-day EMA of $21.94. The stock's position relative to its moving averages suggests resistance from the 50-day and 200-day SMAs. The neutral RSI and negative MACD indicate a lack of strong conviction in either direction, but the price action below key averages points to potential further downside.
Consistent EPS Beats ›
Comcast Corp. (CMCSA) has a track record of exceeding analyst EPS estimates, most recently by 7.22% in July 2026. This suggests effective cost management and operational efficiency.
Source: Earnings ReportsModerate Insider Selling ›
Insiders have sold approximately $2.3 million worth of CMCSA stock across recent filings, resulting in a 'Moderate Sell Signal'. This indicates a degree of profit-taking or portfolio rebalancing among management.
Source: Insider Transactions
Negative Revenue Growth Trend ›
Comcast Corp. (CMCSA) is experiencing negative revenue growth (-1.2%) with forward estimates projecting further declines, indicating challenges in top-line expansion.
Source: Analyst EstimatesAttractive Valuation Metrics ›
The company's P/E ratio of 6.74 and P/S ratio of 0.59 are significantly lower than sector averages, suggesting the stock may be undervalued relative to its peers.
Source: Financial Data
- Consider the substantial dividend yield of 6.06% as a key component of the investment thesis for CMCSA, offering income stability.
- The stock is trading below its 50-day and 200-day moving averages ($24.19 and $26.40), suggesting caution for short-term traders and potential for further downside if these levels are not reclaimed.
Technical indicators
Momentum and trend for CMCSA, from its daily closes.
As of October 16, 2026, with CMCSA at $21.77, its 14-day RSI is 45.8 (neutral territory), its 50-day simple moving average is $24.19 and its 200-day is $26.40.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CMCSA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, CMCSA's 1-year correlation of daily returns is +0.26 with S&P 500 (SPY), +0.15 with Nasdaq 100 (QQQ), -0.01 with Bitcoin (BTC) and -0.03 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
9 of 28 analysts rate it a buy or strong buy, 15 a hold and 4 a sell.Median target above the price ›
The median 12-month target of $28.00 is 28.6% above the price.More buy ratings than three months ago ›
9 of 28 rate it a buy now, against 9 of 28 three months ago.
CMCSA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 2, 2026 | Scotiabank | Maintains | Sector Perform |
| Sep 29, 2026 | Barclays | Maintains | Equal-Weight |
| Sep 28, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Sep 25, 2026 | Keybanc | Downgrade | Underweight |
| Sep 24, 2026 | Citigroup | Maintains | Buy |
| Sep 16, 2026 | B of A Securities | Maintains | Buy |
As of October 16, 2026, 28 Wall Street analysts cover CMCSA: 9 rate it a buy or strong buy, 15 a hold and 4 a sell or strong sell. Their 12-month price targets range from $17.00 to $44.00, with a median of $28.00, 28.6% above the price of $21.77.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CMCSA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CMCSA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CMCSA tends to move, against the market and on its own.
The long record
CMCSA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.99% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 55.6%, from September 2021 to October 2026; the price is still 54.2% below that peak.Most 1-year holds ended higher ›
45% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $9,469.95, against $42,525 in the S&P 500 (SPY).
CMCSA Drawdowns & Recovery
As of October 16, 2026, CMCSA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -55.6% (September 2021 to October 2026); it is still 54.2% below that peak, and 45% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CMCSA in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CMCSA trailed the S&P 500 over this period: $9,469.95 against $42,525.
A $10,000 investment in CMCSA in October 2016 would be worth about $9,470 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CMCSA, and which have not.
Strongest month, November: an average of +4.73%, up in 6 of 10 years.
Weakest month, September: an average of -4.69%, up in 3 of 10 years.
This month, October: has averaged -2.41%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CMCSA's strongest calendar month has been November (average +4.73%, up in 6 of 10 years) and its weakest September (average -4.69%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CMCSA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CMCSA today could grow to about $11,275 by 2036 in the base case, with a 90th-percentile outcome near $33,917 and a 10th-percentile outcome around $3,748. The simulation models price only; at today's 6.06% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CMCSA Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $22.84 for CMCSA by 2030 in the base case, from $21.77 today (1.0x over 4 years). The 10th-percentile path ends near $11.38. These are outcomes of a Monte Carlo simulation run on CMCSA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $15.55 | $22.03 | $31.21 | |
| 2028 | $13.63 | $22.30 | $36.49 | |
| 2029 | $12.35 | $22.57 | $41.25 | |
| 2030 | $11.38 | $22.84 | $45.84 | |
| 2031 | $10.61 | $23.12 | $50.36 |
Method: a lognormal simulation of CMCSA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CMCSA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought CMCSA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, CMCSA insiders reported 3 open-market sales worth $2.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 101.9K | - |
| Aug 17, 2026 | Edward D. Breen
Director
|
Grant | 62.4K | - |
| Jun 30, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.4K | - |
| Jun 30, 2026 | Louise F Brady
Director
|
Grant | 1.4K | - |
| Jun 30, 2026 | Edward D. Breen
Director
|
Grant | 815 | - |
| Jun 30, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.8K | - |
| Jun 30, 2026 | Gordon A Smith
Director
|
Grant | 1.4K | - |
| May 19, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 202.5K | - |
| Apr 2, 2026 | Daniel C Murdock
Officer
|
Grant | 5.3K | - |
| Mar 31, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.2K | - |
| Mar 31, 2026 | Louise F Brady
Director
|
Grant | 1.2K | - |
| Mar 31, 2026 | Edward D. Breen
Director
|
Grant | 697 | - |
| Mar 31, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.5K | - |
| Mar 31, 2026 | Gordon A Smith
Director
|
Grant | 1.2K | - |
| Mar 17, 2026 | Jennifer Khoury
Officer
|
Option | 10.9K | $308.4K |
| Mar 5, 2026 | Jason S Armstrong
Chief Financial Officer
|
Sell | 4.5K | $142.6K |
| Mar 5, 2026 | Jason S Armstrong
Chief Financial Officer
|
Option | 73.5K | $2.1M |
| Feb 27, 2026 | Jason S Armstrong
Chief Financial Officer
|
Grant | 103.5K | - |
| Feb 27, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Grant | 35.0K | - |
| Feb 27, 2026 | Jennifer Khoury
Officer
|
Grant | 9.9K | - |
| Feb 27, 2026 | Daniel C Murdock
Officer
|
Grant | 13.4K | - |
| Feb 27, 2026 | Thomas J Reid
Officer
|
Grant | 93.1K | - |
| Feb 27, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 45.6K | - |
| Feb 11, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Sell | 57.9K | $1.9M |
| Feb 11, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Option | 736.2K | $20.9M |
| Feb 11, 2026 | Brian L Roberts
Chief Executive Officer
|
Option | 984.3K | $27.9M |
| Feb 4, 2026 | Gordon A Smith
Director
|
Grant | 7.9K | - |
| Feb 3, 2026 | Asuka Nakahara
Director
|
Sell | 8.3K | $245.8K |
| Jan 20, 2026 | Jason S Armstrong
Chief Financial Officer
|
Grant | 8.2K | - |
| Jan 20, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.2K | - |
| Jan 20, 2026 | Madeline S Bell
Director
|
Grant | 5.1K | - |
| Jan 20, 2026 | Louise F Brady
Director
|
Grant | 1.2K | - |
| Jan 20, 2026 | Edward D. Breen
Director
|
Grant | 705 | - |
| Jan 20, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.5K | - |
| Jan 20, 2026 | Daniel C Murdock
Officer
|
Grant | 1.6K | - |
| Jan 20, 2026 | Thomas J Reid
Officer
|
Grant | 12.3K | - |
| Nov 20, 2025 | Kenneth J Bacon
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Madeline S Bell
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Louise F Brady
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Edward D. Breen
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Jeffrey A Honickman
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Wonya Y. Lucas
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Asuka Nakahara
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | David C Novak
Director
|
Grant | 9.0K | - |
| Nov 4, 2025 | Brian L Roberts
Chief Executive Officer
|
Grant | 1.7M | - |
| Sep 30, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 1.1K | - |
| Sep 30, 2025 | Louise F Brady
Director
|
Grant | 1.1K | - |
| Sep 30, 2025 | Edward D. Breen
Director
|
Grant | 637 | - |
| Sep 30, 2025 | Jeffrey A Honickman
Director
|
Grant | 1.4K | - |
| Sep 30, 2025 | David C Novak
Director
|
Grant | 1.1K | - |
| Jun 30, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 946 | - |
| Jun 30, 2025 | Louise F Brady
Director
|
Grant | 946 | - |
| Jun 30, 2025 | Edward D. Breen
Director
|
Grant | 561 | - |
| Jun 30, 2025 | Jeffrey A Honickman
Director
|
Grant | 1.2K | - |
| Jun 30, 2025 | David C Novak
Director
|
Grant | 946 | - |
| Jun 18, 2025 | Daniel C Murdock
Officer
|
Grant | 6.8K | - |
| Jun 5, 2025 | Jason S Armstrong
Chief Financial Officer
|
Grant | 9.5K | - |
| May 22, 2025 | Jennifer Khoury
Officer
|
Grant | 15.5K | - |
| May 6, 2025 | Michael J. Cavanagh
President
|
Grant | 171.0K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.